baito logo
    navigation?.buttons?.createJob?.text
    Labor Dr. Wisplinghoff header
    Labor Dr. Wisplinghoff logo
    #medizinischediagnostik #laboruntersuchungen #pathogendiagnostik

    Labor Dr. Wisplinghoff

    from Cologne

    Labor Dr. Wisplinghoff is a leading medical diagnostic laboratory in Cologne that has been providing comprehensive services in laboratory medicine, microbiology, and more since 1977. With innovative technologies and a strong focus on quality, it sustainably improves patient care.

    Visit website

    Labor Dr. Wisplinghoff: A Leading Medical Diagnostic Laboratory

    Labor Dr. Wisplinghoff is a renowned medical diagnostic laboratory based in Cologne, Germany. Founded in 1977, it has developed into one of the largest independent private medical laboratories in Western Europe. The laboratory offers comprehensive diagnostic services in areas such as laboratory medicine, microbiology, pathology, transfusion medicine, toxicology, and human genetics[1][3].

    Key Products and Services

    • NGS-based Pathogen Diagnostics: In partnership with Noscendo, Labor Dr. Wisplinghoff offers Next-Generation Sequencing (NGS) technologies to identify over 1,500 pathogens from a blood sample. This enables rapid and targeted treatment of severely ill patients[1].
    • Central Laboratory Services: Through a strategic alliance with LabConnect, Labor Dr. Wisplinghoff supports clinical studies worldwide with high-quality central laboratory services[5].
    • Forensic Toxicological Analyses: The laboratory offers a comprehensive range of forensic toxicological analyses and is a leader in this field[3].

    Main Mission and Values

    The main mission of Labor Dr. Wisplinghoff is to improve patient care through high-quality laboratory examinations. The company places great importance on innovation, precision, and reliability in medical diagnostics.

    Sustainability Goals and Initiatives

    Although specific sustainability goals are not explicitly mentioned, the commitment to research projects and participation in scientific studies demonstrate the pursuit of continuous improvement and innovation. This is reflected in participation in studies aimed at reducing disease risks and promoting preventive measures[3].

    Current Developments

    Labor Dr. Wisplinghoff is actively involved in research and development of new diagnostic procedures, such as the Stockholm3 blood test for early detection of prostate cancer. These innovations contribute to improving patient care[3].

    Sources: